<DOC>
	<DOCNO>NCT00193375</DOCNO>
	<brief_summary>In multicenter trial , plan evaluate feasibility toxicity initial treatment irinotecan/carboplatin/radiation therapy , follow treatment bevacizumab , patient limit stage small cell lung cancer .</brief_summary>
	<brief_title>Irinotecan , Carboplatin Radiation Therapy Followed Bevacizumab Limited Stage Small Cell Lung Cancer</brief_title>
	<detailed_description>Upon determination eligibility , patient receive : - Irinotecan + Carboplatin + Radiation Therapy + Bevacizumab Patients receive 4 course irinotecan/carboplatin . Radiation therapy begin concurrently third course chemotherapy . The interval chemotherapy course 21 day except interval third fourth course ( radiation therapy ) , 28 day .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>To include study , must meet following criterion : Small cell lung cancer , confirm biopsy . Limited stage disease standard evaluation . Able perform activity daily live without assistance . No previous treatment chemotherapy , radiation therapy , biologics . Measurable evaluable disease Adequate bone marrow , liver kidney function Able understand nature study give write consent . You participate study follow apply : Age &lt; 18 year History previous malignancy Women pregnant lactate History physical exam evidence central nervous system disease ) Active infection require intravenous antibiotic Fulldose anticoagulation thrombolytic therapy within 10 day Proteinuria . Serious nonhealing wound , ulcer , bone fracture Evidence bleed diathesis coagulopathy History heart attack within 6 month . Uncontrolled cardiovascular disease PEG Gtube History serious disease Please note : There additional inclusion/exclusion criterion . The study center determine meet criterion . If qualify trial , study personnel explain reason . If qualify , study personnel explain trial detail answer question may .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>